- Network pharmacology approach to unravel the neuroprotective potential of natural products: a narrative review
- Cytokines as biomarkers of Huntington's disease progression
- Natural Products in the Treatment of Neuroinflammation at Microglia: Recent Trend and Features
- Upregulation of endocannabinoid signaling in vivo restores striatal synaptic plasticity and motor performance in Huntington's disease mice
- Social genetic insurance: A life-cycle perspective
- Role of <em>Achyranthes aspera</em> in neurodegenerative diseases: current evidence and future directions
- Emerging nano-derived therapy for the treatment of dementia: a comprehensive review
- Kinetin mediated mutant huntingtin phosphorylation restores multiple dysregulated pathways in a cell line model of Huntington's disease
- A network pharmacology-based approach to decipher the pharmacological mechanisms of Salvia officinalis in neurodegenerative disorders
- The Double-Edged Sword: The Complex Function of Enteric Glial Cells in Neurodegenerative Diseases
- Mesoscale Imaging of Cortical Sensorimotor Integration in Huntington's Disease Mice During Reward-Guided Behaviour
- Opposing roles for GSK3beta and ERK1-dependent phosphorylation of huntingtin during neuronal dysfunction and cell death in Huntington's disease
- Comparison of the Clinical Spectrum of Juvenile- and Adult-Onset Huntington Disease: A National Cohort and Enroll-HD Observational Study
- Juvenile Huntington Disease: Timing Is Everything
- FOXOs and their roles in acute and chronic neurological disorders
- Wearable, High-Density, Time-Domain Diffuse Optical Tomography Array for Functional Neuroimaging
- Intersecting impact of CAG repeat and huntingtin knockout in stem cell-derived cortical neurons
- Challenges and advances for huntingtin detection in cerebrospinal fluid: in support of relative quantification
- A 14-Year Study of Serum Glial Fibrillary Acidic Protein and Total Tau in Premanifest Huntington's
- Utilizing Sertoli Cell Transplantation as a Therapeutic Technique for the Management of Neurodegenerative Diseases
- Differentiating Hyperkinetic and Hypokinetic Motor Features in the Progression of Huntingtons Disease
- Oxytocin Anti-Apoptotic Potential Mediates Neuroprotection Against 3-Nitropropionic Acid-Induced Huntington's Disease-Like Pathophysiology in Rats: Involvement of Calpain-2/p25 Cdk5/MEF-2 Signaling Pathway
- Online HD-tRNS over the right temporoparietal junction modulates social inference but not motor coordination
- Lipid Droplet in Lipodystrophy and Neurodegeneration
- Generating the head direction signal: Two types of head direction cells in the lateral mammillary and dorsal tegmental nuclei.
- Early Language Impairment as an Integral Part of the Cognitive Phenotype in Huntington's Disease
- Examination of Anti-Inflammatory Effects After Propionate Supplementation in the R6/2 Mouse Model of Huntington's Disease
- Unraveling Molecular Targets for Neurodegenerative Diseases Through <em>Caenorhabditis elegans</em> Models
- Interferon Regulatory Factors as a Potential Therapeutic Target for Neuroinflammation: A Focus on Alzheimer's Disease
- Huntington's disease caregivers: A qualitative exploration of caregivers experience
- DNA binding and mitotic phosphorylation protect polyglutamine proteins from assembly formation
- Development of GluN2A NMDA receptor positive allosteric modulators: Recent advances and perspectives
- Alpha-Pinene Ameliorates Memory Deficits in 3-Nitropropionic Acid-Induced Rat Model of Huntington's Disease
- Characterization of the intraspecies chimeric mouse brain at embryonic day 12.5
- Inhibitor-based modulation of huntingtin aggregation mechanisms mitigates fibril-induced cellular stress
- Functional Rating Scale 2.0 (FuRST 2.0): A patient-reported outcome measure of function for Huntington's disease
- The role of Panax ginseng in neurodegenerative disorders: mechanisms, benefits, and future directions
- Thymoquinone-loaded solid lipid nanoparticles mitigate 3-Nitropropionic acid-induced mitochondrial dysfunction and oxidative damage via regulating PGC-1α/Nrf2 pathway
- Sleep abnormalities are associated with greater cognitive deficits and disease activity in Huntington's disease: a 12-year polysomnographic study
- CO2 sensitive connexin channel synapses in the VTA release 5HT to regulate dopaminergic neurons
- Effect of stress on neuronal cell: Morphological to molecular approach
- Asymmetric brain atrophy in Huntington's disease: A postmortem MRI study
- CD200-based cell sorting results in homogeneous transplantable striatal neuroblasts for human cell therapy for Huntington's disease
- Adult-onset Niemann-Pick disease type C presenting as progressive chorea mimicking Huntington's disease
- Nicotinamide N-methyltransferase as a potential therapeutic target for neurodegenerative disorders: Mechanisms, challenges, and future directions
- Investigating the Therapeutic Potential of the Ketogenic Diet in Modulating Neurodegenerative Pathophysiology: An Interdisciplinary Approach
- Neuroprotective role of morin hydrate on 3-nitropropionic acid-elicited huntington's disease: in vivo investigation of RIPK1/RIPK3/MLKL necroptosis signaling pathway
- A digital motor score for sensitive detection of progression in Huntington's disease
- Basal ganglia contributions to social cognition: evidence from movement disorders
- Huntington's Disease and Dentistry: A Review of Its Etiology, Clinical Presentation, Symptomatic Pharmacotherapy, and Dental Management
- Rehabilitation of Women with Neurodegenerative Diseases
- Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases
- Altered Huntingtin-Chromatin Interactions Predict Transcriptional and Epigenetic Changes in Huntington's Disease Mouse Models
- Mutant huntingtin induces neuronal apoptosis via derepressing the non-canonical poly(A) polymerase PAPD5
- Unravelling the role of protein kinase R (PKR) in neurodegenerative disease: a review
- Pharmacodynamic biomarkers responsive to mutant huntingtin lowering in a Huntington's disease mouse model
- Structural and functional neuroplasticity in music and dance-based rehabilitation: a systematic review
- The mechanism of super-enhancer regulation of gene expression and research progress in neurodegenerative diseases
- Exploring Cordycepin as a Neuroprotective Agent in Huntington's Disease: In Vitro and In Vivo Insights
- Diffusion along Perivascular Spaces as a Marker for Glymphatic System Impairment in Huntington's Disease
- Newly generated striatal neurons rescue motor circuitry in a Huntington's disease mouse model
- Incidence and health burden of 20 rare neurological diseases in South China from 2016 to 2022: a hospital-based observational study
- Genome Editing in Medicine: A Scoping Review of Ethical, Bioethical, and Medico-Legal Implications
- Evaluation of a Small Molecule Genetic Medicine RTX-317 in Preclinical Models of Huntington's Disease (P10-5.010)
- Alkaloids as neuroprotectors: targeting signaling pathways in neurodegenerative diseases
- Neuropsychiatric Diagnoses Associated with Neurofibromatosis Type 1 in the TriNetX Research Network (P9-6.004)
- Medication Reduction After Bilateral Globus Pallidus Internus Deep Brain Stimulation (P2-5.032)
- NINDS-Supported Biospecimen Repositories: BioSEND and NHCDR (S13.005)
- The pharmacodynamics-based prophylactic benefits of GLP-1 receptor agonists and SGLT2 inhibitors on neurodegenerative diseases: evidence from a network meta-analysis
- Redox chemical delivery system: an innovative strategy for the treatment of neurodegenerative diseases
- Activating autophagy to eliminate toxic protein aggregates with small molecules in neurodegenerative diseases
- West-Central African Ancestry of the Repeat-Expansion Founder Mutation on the JPH3 Gene in Mexican Patients With Huntington's Disease-Like 2
- Correction: Longitudinal Treatment Patterns of Chorea in North American Patients with Huntington's Disease: Data from Enroll-HD
- Long Somatic DNA-Repeat Expansion Responsible for Clinical Findings in Huntington's Disease
- Natural products in neurodegenerative diseases: recent advances and future outlook
- Sida cordifolia is efficacious in models of Huntington's disease by reducing ER stress
- Suicidal Ideation and Sleep Disturbances Among People With Huntington Disease: Evidence From the HDBOI Study
- A systematic review of performance-based functional capacity measures for use in Huntington's disease and evaluation of their suitability for clinical trials
- Gangliosides Modulate the Secretion of Extracellular Vesicles and Their Misfolded Protein Cargo
- CAG-targeted brain-permeable therapy tested in biallelic humanized polyQ mouse models
- Multi-epitope immunocapture of huntingtin reveals striatum-selective molecular signatures
- Rare Diseases, Spotlighting Amyotrophic Lateral Sclerosis, Huntington's Disease, and Myasthenia Gravis: Insights from Landscape Analysis of Current Research
- The targeting of non-fibrillar polyQ via distinct VCP-proteasome coupling
- Progressively reduced cerebral oxygen metabolism and elevated plasma NfL levels in the zQ175DN mouse model of Huntington's disease
- Interrogating DNA methylation associated with Lewy body pathology in a cross brain-region and multi-cohort study
- Uncovering synaptic and cellular nanoarchitecture of brain tissue via seamless <em>in situ</em> trimming and milling for cryo-electron tomography
- 1953-2023. Seventy Years of the Nerve Growth Factor: A Potential Novel Treatment in Neurological Diseases?
- Phytochemicals Targeting BDNF Signaling for Treating Neurological Disorders
- Emerging roles of microglia and neuroinflammation in Huntington's disease: From pathophysiology to clinical trials
- The glymphatic system in Huntington's disease
- Statistical analysis of correlated expression data from high throughput experiments
- Dual-mode sensing platform based on an iodide ion synergistic covalent triazine frameworks (CTFs) for point-of-care testing (POCT) of acetylcholinesterase
- Heat shock proteins in protein folding and reactivation
- A TMT-Based Proteomic Analysis of Osmoregulation in the Gills of <em>Oreochromis mossambicus</em> Exposed to Three Osmotic Stresses
- ONT in Clinical Diagnostics of Repeat Expansion Disorders: Detection and Reporting Challenges
- Potential targets of microglia in the treatment of neurodegenerative diseases: mechanism and therapeutic implications
- Profiling Swallowing Safety and Physiology in People With Huntington's Disease
- Flavonoids and their role in oxidative stress, inflammation, and human diseases
- Neuroglia in neurodegeneration: Alzheimer, Parkinson, and Huntington disease
- Flavonoids in the regulation of microglial-mediated neuroinflammation; focus on fisetin, rutin, and quercetin
